The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Obesity pill shows promising results

| | February 10, 2015

Forget the so-called “miracle” diet pills that claim to rev up metabolism.

Slowly but surely, we’re entering a new era of clinically tested drugs to combat obesity; most of the newest ones try to do that by suppressing appetite. And while no one’s giving up on old-fashioned diet and exercise to help people lose weight, more scientists are convinced that drugs will become a good option for some of the one-third of American adults who are obese and at risk of obesity-related diseases like diabetes and hypertension. (Insurers don’t yet seem to agree.)

When we heard about a new pill researchers say could act like an “imaginary meal,” tricking the digestive system into burning fat even without any food, we were intrigued. Big caveat, though, before we dive into the details: So far, this pill has only been tested in mice and is at least a year away from its first trial in humans.

Leading the research into this compound, called fexaramine, is Ronald Evans, director of the Gene Expression Laboratory at the Salk Institute for Biological Studies in California. He and a team of other researchers published a paper in Nature Medicine in January showing that fexaramine reduced weight gain, inflammation and helped turn white fat (which stores calories) into brown fat (which burns calories) in overweight mice compared to a control group. Evans tells The Salt he has a lot of reasons to be optimistic it will work well in humans, too.

Read full, original article: Scientists Want To Trick The Gut Into Burning Fat Without Food

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend